Skip To Main Content
Yinge Wu on Muck Rack

Yinge Wu

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinge

Contact Yinge, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Author Correction: Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021 | Scientific Reports

|
By Ziming Yang, Aolin Li, Yuling Jiang, Xiagela Maidaiti, Yinge Wu
| Nature Verified
Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-72795-0, published online 27 September 2024 In the original version of this Article, Figure 5 was incorrectly displayed. The original Figure 5 and the accompanying legend appear below. The trends between SDI and the burden of HFPG-attributable MASLD across 204 countries and territories and 21 GBD regions, 1990–2021. (A) ASDRs in 2021; (B) ASMRs in 2021; (C) ASDRs and PAFs of ASD across 21 GBD regions, 1990–2021.
Open in Who Shared View Duplicates (9) Issue with article?

Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021 | Scientific Reports

|
By Ziming Yang, Aolin Li, Yuling Jiang, Xiagela Maidaiti, Yinge Wu
| Nature Verified
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) brings heavy clinical and economic burdens to patients worldwide. High fasting plasma glucose (HFPG) was proven to be an important modifiable risk factor. However, the global burden distribution of HFPG-attributable MASLD has not been fully studied. This study aimed to describe the epidemiological distribution and trends of the burden of HFPG-attributable MASLD worldwide.
Open in Who Shared Issue with article?
See all 2 articles